Skip to Main Content

Paper Details

Association Between Baseline Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers and Death Among Patients Tested for COVID-19.
J Clin Pharmacol
4
2022
Angiotensin Receptor, Angiotensin-Converting Enzyme, Angiotensin-converting enzyme, COVID-19, Patients, Respiratory failure, SARS, SARS-, SARS-CoV, SARS-CoV-2, angiotensin receptor, coronavirus 2, patients, renal failure, respiratory failure, severe acute respiratory syndrome
Author NameAffiliation
Michael A Puskarich
Carlos A CamargoHarvard Medical School, Massachusetts General Hospital
Carlos A CamargoHarvard Medical School, Massachusetts General Hospital
Daniel Mark CourtneyUT Southwestern Medical Center
  • 1 - 4

Datasets

Release 1.2